Suppr超能文献

[遗传性视神经萎缩的遗传病因与基因诊断检测]

[Genetic Causes and Genetic Diagnostic Testing of Inherited Optic Atrophies].

作者信息

Wissinger Bernd

机构信息

Molekulargenetisches Labor, Department für Augenheilkunde, Universität Tübingen.

出版信息

Klin Monbl Augenheilkd. 2018 Nov;235(11):1235-1241. doi: 10.1055/a-0759-2094. Epub 2018 Nov 20.

Abstract

Hereditary optic atrophies are a heterogeneous group of rare degenerative disease affecting the retinal ganglion cells and their axons which form the optic nerve. With an estimated prevalence of 1 : 10 000 to 1 : 20 000, hereditary optic atrophies in their entirety affect about 4000 to 8000 people in Germany. The most common forms are Leber's hereditary optic atrophy (LHON) and autosomal dominant optic atrophy (ADOA). Besides the common forms of isolated optic atrophies which exclusively affect the visual system, there are a variety of conditions in which the optic atrophy is part of a syndromic disease with additional symptoms that are mostly neurosensory, neurological or neuromuscular. The mode of inheritance is heterogeneous with LHON showing maternal inheritance and an autosomal dominant inheritance in families with ADOA. There are rarer cases of optic atrophy following an autosomal recessive or X-linked recessive mode of inheritance. The penetrance is incomplete. Moreover, in LHON, there are many more males than females who develop the disease. The genetic causes of hereditary optic atrophies are complex in terms of the diversity of the involved genes. However, most of these causes are already known. Therefore, molecular genetic diagnostic testing yields a meaningful result in the majority of tested subjects and enables confirmation of the suspected clinical diagnosis, reliable counseling of the families with respect to the genetic risk, and - in subjects with genetically confirmed LHON - initiation of therapeutic intervention. This article provides an overview of current knowledge of the genetic causes of hereditary optic neuropathies, and the options and modalities of molecular genetic diagnostic testing, including practical guidelines.

摘要

遗传性视神经萎缩是一组异质性的罕见退行性疾病,影响视网膜神经节细胞及其形成视神经的轴突。据估计,其患病率为1:10000至1:20000,在德国,遗传性视神经萎缩患者总数约为4000至8000人。最常见的类型是Leber遗传性视神经病变(LHON)和常染色体显性遗传性视神经萎缩(ADOA)。除了仅影响视觉系统的常见孤立性视神经萎缩类型外,还有多种情况,其中视神经萎缩是综合征性疾病的一部分,伴有其他症状,这些症状大多为神经感觉性、神经性或神经肌肉性。遗传方式具有异质性,LHON表现为母系遗传,而ADOA家族为常染色体显性遗传。也有罕见的常染色体隐性或X连锁隐性遗传方式导致的视神经萎缩病例。外显率不完全。此外,在LHON患者中,男性发病者比女性多得多。就所涉及基因的多样性而言,遗传性视神经萎缩的遗传原因很复杂。然而,其中大多数原因已为人所知。因此,分子遗传学诊断检测在大多数受检者中能得出有意义的结果,有助于确认疑似临床诊断,为家族提供关于遗传风险的可靠咨询,并且——对于基因确诊为LHON的患者——启动治疗干预。本文概述了遗传性视神经病变遗传原因的当前知识,以及分子遗传学诊断检测的选择和方式,包括实用指南。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验